Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$234.74 - $275.42 $5,399 - $6,334
-23 Reduced 2.52%
890 $219,000
Q1 2022

May 09, 2022

BUY
$243.64 - $270.48 $4,385 - $4,868
18 Added 2.01%
913 $231,000
Q4 2021

Feb 11, 2022

BUY
$230.08 - $250.94 $205,921 - $224,591
895 New
895 $225,000
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $24,137 - $26,715
-104 Closed
0 $0
Q4 2020

Jan 11, 2021

SELL
$221.92 - $245.94 $10,208 - $11,313
-46 Reduced 30.67%
104 $26,000
Q3 2020

Oct 09, 2020

SELL
$215.77 - $276.76 $28,481 - $36,532
-132 Reduced 46.81%
150 $34,000
Q2 2020

Jul 07, 2020

SELL
$219.9 - $263.41 $21,990 - $26,341
-100 Reduced 26.18%
282 $67,000
Q1 2020

Apr 20, 2020

SELL
$195.69 - $279.01 $52,836 - $75,332
-270 Reduced 41.41%
382 $87,000
Q4 2019

Jan 27, 2020

BUY
$236.45 - $266.82 $154,165 - $173,966
652 New
652 $177,000
Q3 2019

Oct 09, 2019

SELL
$230.58 - $256.08 $23,288 - $25,864
-101 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$217.4 - $246.08 $21,957 - $24,854
101 New
101 $25,000
Q1 2019

Apr 25, 2019

SELL
$206.05 - $248.17 $582,503 - $701,576
-2,827 Closed
0 $0
Q4 2018

Jan 14, 2019

BUY
$204.73 - $257.93 $13,102 - $16,507
64 Added 2.32%
2,827 $637,000
Q3 2018

Oct 18, 2018

SELL
$233.07 - $256.0 $233 - $256
-1 Reduced 0.04%
2,763 $0
Q2 2018

Jul 13, 2018

BUY
$208.1 - $233.85 $79,286 - $89,096
381 Added 15.99%
2,764 $662,000
Q1 2018

Apr 25, 2018

BUY
$205.46 - $240.27 $17,875 - $20,903
87 Added 3.79%
2,383 $516,000
Q4 2017

Jan 19, 2018

BUY
$189.0 - $222.64 $433,944 - $511,181
2,296
2,296 $491,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.